BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 38540191)

  • 1. The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review.
    Kasprzak A; Geltz A
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin and Its Receptor System in Colorectal Cancer.
    Kasprzak A
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.
    Herrera-Martínez AD; Gahete MD; Pedraza-Arevalo S; Sánchez-Sánchez R; Ortega-Salas R; Serrano-Blanch R; Luque RM; Gálvez-Moreno MA; Castaño JP
    Endocrine; 2018 Feb; 59(2):426-437. PubMed ID: 29196939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.
    Ungefroren H; Künstner A; Busch H; Franzenburg S; Luley K; Viol F; Schrader J; Konukiewitz B; Wellner UF; Meyhöfer SM; Keck T; Marquardt JU; Lehnert H
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors.
    Sollini M; Erba PA; Fraternali A; Casali M; Di Paolo ML; Froio A; Frasoldati A; Versari A
    ScientificWorldJournal; 2014; 2014():194123. PubMed ID: 24693229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.
    Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide receptor targeting in cancer: the somatostatin paradigm.
    Barbieri F; Bajetto A; Pattarozzi A; Gatti M; Würth R; Thellung S; Corsaro A; Villa V; Nizzari M; Florio T
    Int J Pept; 2013; 2013():926295. PubMed ID: 23476673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA.
    Luque RM; Park S; Peng XD; Delgado E; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2004 Apr; 32(2):437-48. PubMed ID: 15072550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer.
    Klomp MJ; Dalm SU; de Jong M; Feelders RA; Hofland J; Hofland LJ
    Rev Endocr Metab Disord; 2021 Sep; 22(3):495-510. PubMed ID: 33085037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization of somatostatin receptors in brain and periphery.
    Csaba Z; Dournaud P
    Prog Mol Biol Transl Sci; 2023; 196():43-57. PubMed ID: 36813365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin.
    Dal Monte M; Martini D; Ristori C; Azara D; Armani C; Balbarini A; Bagnoli P
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):593-612. PubMed ID: 21523559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues--Observations in two patients with acromegaly and severe headache.
    Marina D; Burman P; Klose M; Casar-Borota O; Luque RM; Castaño JP; Feldt-Rasmussen U
    Growth Horm IGF Res; 2015 Oct; 25(5):262-7. PubMed ID: 26188991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.
    Cakir M; Dworakowska D; Grossman A
    J Cell Mol Med; 2010 Nov; 14(11):2570-84. PubMed ID: 20629989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptors.
    Møller LN; Stidsen CE; Hartmann B; Holst JJ
    Biochim Biophys Acta; 2003 Sep; 1616(1):1-84. PubMed ID: 14507421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin.
    Sáez-Martínez P; Porcel-Pastrana F; Pérez-Gómez JM; Pedraza-Arévalo S; Gómez-Gómez E; Jiménez-Vacas JM; Gahete MD; Luque RM
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361790
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.